Waltz Health and Fresenius Kabi are moving to offer three biosimilars through a direct-to-payer model, bypassing traditional wholesaler and pharmacy benefit manager rebate channels entirely. The partnership represents a significant shift in
The FTSE 100 and FTSE 250 indices have been reaching record levels in 2026, reflecting a broadly optimistic mood across UK equity markets. Despite the strong overall performance, experienced investors know that
More
AstraZeneca (AZN) and CSPC Pharmaceutical Group have signed a joint venture contract to construct a new-generation biologics manufacturing facility in Shijiazhuang, China. The agreement marks the third strategic deal the two companies
More
On July 14, 2026, Governor Kathy Hochul signed Executive Order No. 62, imposing a temporary statewide moratorium on data center projects across New York. The order makes New York the first state
More
Milbank appears to be keeping its lawyers well occupied, with the prominent law firm drawing attention for its latest compensation activity in August 2026. The firm has announced special bonuses to be
More
The FTSE 250 index has climbed to record highs, marking a significant milestone for mid-cap UK stocks and signalling renewed investor confidence in British equities. The index, which tracks the 250 largest
More
Emergent BioSolutions has undergone a series of sweeping restructuring efforts, eliminating senior roles and consolidating operations as part of a broad turnaround strategy. Joseph Papa, just two months into his role as
More
Employers across the United States are sitting on vast stores of workforce data that could help them avoid costly wage-and-hour disputes before they escalate. Most businesses already hold the relevant information inside
More
The conflict between Russia and Ukraine remains the largest and most destructive European war since the Second World War ended in 1945. Observers across the political spectrum have described it as one
More
4Imprint Group (FOUR) saw its shares climb sharply after the promotional products company published results that impressed investors across the market. The FTSE 250-listed business, which specialises in branded merchandise and direct
More
Eli Lilly’s second-quarter revenues surged to $23 billion, a 48% year-over-year increase that comfortably beat analyst consensus estimates of $20.6 billion. The result also represented a 16% sequential increase, a sharp acceleration
More